Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing
Source: FirstWord
One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds
Source: USA Today
Source: FiercePharma
Latest News
02.25.21
Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical TestingSource: FirstWord
02.25.21
Allergan Submits New Drug Application for Investigational Eye Drop for the Treatment of PresbyopiaSource: Allergan
02.24.21
New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Beyond Acute Disease into Chronic PhaseSource: Horizon Therapeutics
02.24.21
One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report FindsSource: USA Today
02.24.21
International Team Identifies 127 Glaucoma Genes in Largest Study of Its KindSource: Massachusetts Eye and Ear
02.24.21
Pfizer, Moderna and J&J Tout Supercharged COVID-19 Vaccine Output, Eyeing Nearly 140 Million New Doses by MarchSource: FiercePharma
02.23.21
FCI Ophthalmics Announces Availability of LacriJet for Monocanalicular Nasolacrimal IntubationSource: FCI Ophthalmics
02.23.21
Lexitas Announces George N. Magrath, MD, MBA Assumes Role of Chief Executive OfficerSource: Lexitas
02.23.21
Bausch + Lomb Launches Alaway Preservative Free Antihistamine Eye DropsSource: Bausch + Lomb
02.23.21
AcuFocus Submits US Premarket Approval Application to the FDA for Its IC-8 Small Aperture IOLSource: AcuFocus
02.23.21
Optimo Medical and Ansys Partner Announce Partnership to Improve Surgery PreparationSource: Optimo Medical